Search

everythinglearnresearchcommunity

for

Search:↓

Endocrine therapies for cancer significantly increase the risk of hair loss.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Scalp cooling effectively prevents hair loss during chemotherapy in most cases.

Scalp cooling helps prevent hair loss during chemotherapy, and minoxidil aids regrowth.

Silastic-Dacron strips effectively prevent stretch-back after hair reduction surgeries.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Melanoma development can be linked to the breakdown of skin's melanin-producing units.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

A new suturing technique for hair transplant donor sites leads to better scarring and allows more grafts to be taken.

Scalp lifting surgery can safely and effectively reduce baldness if done with careful planning and proper technique.

Incisional slit grafting for hair transplantation gives natural-looking results and has a high success rate.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Lysocellin helps stop cell damage from etoposide and may prevent hair loss.

New techniques and findings in dermatologic surgery show improved pain management, safer liposuction, better hair transplantation, and effective treatments for skin conditions.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

FFA has higher long-term remission rates than LPP.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Scalp cooling prevented hair loss in half of the patients, despite significant side effects.